175 related articles for article (PubMed ID: 12224020)
1. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma.
Sauter ER; Takemoto R; Litwin S; Herlyn M
Cancer Gene Ther; 2002 Oct; 9(10):807-12. PubMed ID: 12224020
[TBL] [Abstract][Full Text] [Related]
2. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
[TBL] [Abstract][Full Text] [Related]
3. Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors.
Dummer R; Bergh J; Karlsson Y; Horowitz JA; Mulder NH; Huinink DTB ; Burg G; Hofbauer G; Osanto S
Cancer Gene Ther; 2000 Jul; 7(7):1069-76. PubMed ID: 10917210
[TBL] [Abstract][Full Text] [Related]
4. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
6. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas.
Sauter ER; Nesbit M; Litwin S; Klein-Szanto AJ; Cheffetz S; Herlyn M
Cancer Res; 1999 Oct; 59(19):4876-81. PubMed ID: 10519399
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppression without differentiation or apoptosis by antisense cyclin D1 gene transfer in K1735 melanoma involves induction of p53, p21WAF1 and superoxide dismutases.
Rieber M; Rieber MS
Cell Death Differ; 1999 Dec; 6(12):1209-15. PubMed ID: 10637437
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity.
Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE
Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348
[TBL] [Abstract][Full Text] [Related]
12. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
13. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
[TBL] [Abstract][Full Text] [Related]
14. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type.
Sasaki T; Katayose Y; Suzuki M; Yamamoto K; Shiraso S; Mizuma M; Unno M; Takeuchi H; Lee CT; Matsuno S
Hepatogastroenterology; 2004; 51(55):68-75. PubMed ID: 15011833
[TBL] [Abstract][Full Text] [Related]
16. Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.
Hori M; Suzuki K; Udono MU; Yamauchi M; Mine M; Watanabe M; Kondo S; Hozumi Y
Arch Dermatol Res; 2009 Oct; 301(9):631-46. PubMed ID: 19009304
[TBL] [Abstract][Full Text] [Related]
17. Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells.
Cascalló M; Mercadé E; Capellà G; Lluís F; Fillat C; Gómez-Foix AM; Mazo A
Cancer Gene Ther; 1999; 6(5):428-36. PubMed ID: 10505853
[TBL] [Abstract][Full Text] [Related]
18. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
19. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK
Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]